In a recent comprehensive review, an international group of experts analysed published and unpublished data on IgA aCL and aβ2GPI, highlighting the low quality of the data, variability of results and that many studies had been restricted to patients with SLE [41]. The gene discussed is CD79A; the disease is systemic lupus erythematosus.